We have previously shown that reduction of ischaemic cell swelling via enhanced cell volume regulation is a key mechanism of ischaemic preconditioning (IPC) in cardiomyocytes. We have also shown that pharmacological blockade of Cl 2 channels abolishes cardioprotection achieved by IPC in Langendorff-perfused hearts and freshly isolated cardiomyocytes, thus suggesting that Cl 2 plays a key role in IPC cardioprotection. However, direct evidence of Cl 2 channel activation resulting in transsarcolemmal Cl 2 efflux by IPC had been lacking. To address this issue, 24 h cultured rabbit cardiomyocytes were loaded with 5 mM 6-methoxy-N-(3-sulfopropyl)quinolinium (SPQ), a specific fluorescence indicator that is quenched by Cl 2 so that cellular efflux of Cl 2 results in an increase in SPQ fluorescence.
Introduction
Ischaemic preconditioning (IPC), an innate protective phenomenon occurring in the heart, is triggered by short brief episodes of myocardial ischaemia and reperfusion to protect the myocardium against a subsequent sustained episode of ischaemia and reperfusion. This protective phenomenon has been extensively studied in several animal species and is believed to exist in human hearts. 1 IPC cardioprotection is triggered by activation of a number of sarcolemmal membrane receptors in response to the release of their specific endogenous receptor agonist (e.g. adenosine, bradykinin, and opioids) during brief ischaemia and reperfusion. These membrane receptors, once activated, place in motion cellular downstream pathways leading to activation of protective signalling in the mitochondria that is thought to promote the mitochondrial permeability transition pore (MPTP) remaining in a closed state, thus preventing cell death following prolonged ischaemia and reperfusion in cardiomyocytes. 1, 2 Multiple downstream protein kinases (e.g. MAP kinases, PI3 kinase, and PKC) act as mediators of IPC cardioprotection through the mitochondrial signalling. 2 However, these kinases may also signal to non-mitochondrial targets, and very little is known about the participation of other non-mitochondrial downstream effectors in IPC cardioprotection. On the basis of the importance of Cl 2 transport in cell volume regulation in various cell types, 3 -5 we have suggested that sarcolemmal Cl 2 channel activity plays a key role in IPC protection against oncotic (necrotic) cell death, in which cell swelling is prominent, resulting from ischaemia/reperfusion in the myocardium. We have shown that pharmacological inhibition of Cl 2 channels abolished protection induced by preconditioning, both following brief preconditioning ischaemia 6 
Methods
The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Experimental animal protocols were approved by the Animal Care Committee at our institution.
Preparation of cardiomyocyte primary cultures
Cardiomyocytes were first isolated form New Zealand adult white rabbit (3 -3.5 kg) hearts by enzymatic digestion as we have described previously. 6, 7 After isolation, ventricular cardiomyocytes were placed on a circular laminin-coated glass slide (35 mm diameter) (Bioptechs Inc., USA) that was already immersed in culture medium 199 with Earle's salts (Gibco, Canada) and supplemented with 10% FBS, 10 mM cytosine b-D-arabinofuranoside, 100 IU/mL penicillin, 100 mg/mL streptomycin, and 0.08 mg/mL gentamicin in a 60 mm diameter Petri dish. Culture medium was exchanged once for freshly prepared medium after 24 h in culture. Only cell culture plates with more than 75% rod-shaped viable cardiomyocytes were used in these studies. 11 -13 but not previously in cardiomyocytes.
Experimental preparation
Glass slides with SPQ-loaded cardiomyocytes were placed into a closed (308 mm   3 ) heating chamber (Bioptechs Inc.). This chamber system, with its microaqueduct slide, allows for maintenance of an accurate control of both temperature and a near laminar flow perfusion. Heating chamber temperature was maintained at 378C and continuously monitored using a temperature-sensitive colour dot that was placed on top of the microaqueduct slide. Once the chamber was assembled, it was mounted on the stage of an inverted Leica DMIRE2 microscope (Leica Microsystems Inc., Canada). Then, cardiomyocytes were incubated in medium 199 supplemented with 5% FBS for 10 min to stabilize prior to any intervention. The media was exchanged, as required, via a low perfusion pressure column (13 cmH 2 O, flow rate of 2.2 mL/min) attached to an input tubing connected to the chamber microaqueduct. After stabilization, three to four microscopic fields, with four to six cardiomyocytes visualized (×20 magnification) per field, were marked using a computercontrolled motorized Leica DMSTC X-Y stage (Leica Microsystems Inc.). SPQ fluorescence was excited at 350 nm using UV light, and fluorescence, emitted at 460 nm, was recorded using an A4 filter cube (360 + 40 nm excitation range and 470 + 40 nm emission range). Cardiomyocyte fluorescence images were recorded using a QImaging Retiga EX CCD digital camera (Burnaby, Canada) attached to the inverted microscope. After stabilization, two baseline images (time ¼ 0 min) were acquired for each field. The bright field image was first taken using a 12 V Halogen lamp. The second image was taken using a UV lamp source and the A4 filter cube, at 200 ms exposure time. Next, the stabilization medium was then quickly exchanged for the appropriate experimental solution and allowed to stabilize in the new solution for 10 min before the next data acquisition point. Cardiomyocyte images were acquired using OpenLab software (Improvisions Inc., USA). SPQ fluorescence intensities were then measured on digital images using the NIH Image software (US NIH, USA). The average fluorescence intensity within a region of interest (ROI) was measured in each cardiomyocyte. Each ROI was obtained by tracing out the perimeter of each cardiomyocyte. The fluorescence intensity measurements from cardiomyocyte images were corrected by subtracting from each image a background fluorescence value obtained from an adjacent area to the ROI. Only rod-shaped, well into focus, and non-overlapping cardiomyocytes were used.
Calibration of intracellular SPQ fluorescence
Intracellular calibration of SPQ fluorescence was performed using a two-point ionophore-based method as described previously. 14 -16 Initially, to obtain the first calibration point (maximum fluorescence), cardiomyocytes were allowed to equilibrate for 10 min in a 0 mM 14 to obtain the second calibration point (minimum fluorescence representing the background fluorescence). The SPQ fluorescence data obtained from this calibration procedure in cardiomyocytes were fitted to the Stern-Volmer equation (1) 
Here, F 0 and F are the fluorescence intensities in the absence (minus background fluorescence) and presence (minus background fluorescence) of the quencher (Cl 2 ), respectively. K sv is the Stern-Volmer constant, the magnitude of which depicts the halide concentration range detectable. From Eq. (1), we calculated the K sv as follows: 
SPQ leakage and photo-bleaching
Once loaded into the cardiomyocyte, SPQ fluorescence intensity can decrease as a result of leakage of SPQ to the extracellular medium or photo-bleaching. To determine the net loss of fluorescence over the duration of the experiments, we measured the decrease in SPQ fluorescence over time in 24 h cultured cardiomyocytes. Measurement of Cl 2 efflux in cardiomyocytes SPQ fluorescence was first measured in preliminary experiments following incubation of cardiomyocytes in a physiological buffer (medium 199) for up to 60 min. Then medium was exchanged with medium 199 containing 150 mM KSCN and 5 mM valinomycin to quench the SPQ fluorescence. With this approach, we had a low SPQ fluorescence with a high signal-to-noise ratio. We were able to increase this signal-to-noise ratio to more than 100:1 by enhancing the SPQ fluorescence in cardiomyocytes using a buffer solution containing 0 mM Cl 2 . Cells were then incubated for 10 min in stabilization buffer containing Cl 2 at physiological concentration (114.5 mM) supplemented with KSCN and valinomycin (used at the same concentration as indicated above) to determine the lowest fluorescence intensity (background fluorescence). In preliminary experiments in cardiomyocytes, administration of KSCN alone produced only moderate quenching of SPQ fluorescence (see Supplementary material online). The reduction of the maximum SPQ fluorescence intensity in the absence of Cl 2 (minus background fluorescence) was measured to determine the extent of SPQ fluorescence loss over time. Photo-bleaching from exposure to UV light and photodynamic cell injury were minimized or prevented by using an automated shutter and by limiting UV light exposure time to 200 ms during each image acquisition. Using this methodology, the rate of SPQ leakage was measured as the change in the percentage of SPQ fluorescence (minus background fluorescence) over time.
Measurement of Cl 2 efflux in cardiomyocytes
In these studies, the effect of IPC and adenosine A 1 /A 3 receptor activation with APNEA on Cl 2 efflux, when compared with non-preconditioned and vehicle treatment, respectively, was assessed in 24 h cultured cardiomyocytes using the Cl 2 indicator SPQ. After 30 min stabilization in culture medium 199 with 0.1% BSA, cardiomyocytes subject to IPC were bathed in a hypoxic ( 8% O 2 ) solution (IPC solution) containing (in mM) 139 NaCl, 4.7 KCl, 0.5 MgCl 2 , 1.0 CaCl 2 , 5 HEPES, 10 2-deoxy-D-glucose, and 0.1% BSA (pH 7.4, at 378C) for 10 min as we have described previously. 8 Next, cardiomyocytes were bathed in oxygenated culture medium 199 with 0.1% BSA for 20 min. Control (nonpreconditioned) cardiomyocytes were bathed in oxygenated buffer solution of similar composition as the IPC solution described above but containing 10 mM of glucose (instead of 2-deoxy-D-glucose) and incubated (at 378C) for 10 min. Pharmacologically preconditioned cardiomyocytes were bathed, after stabilization, with oxygenated medium 199 with 0.1% BSA containing either 1 mM APNEA or vehicle (DMSO 0.01% v/v) for 10 min. Next, each group of cardiomyocytes were either re-oxygenated or washed with medium 199 (with 0.1% BSA) for 10 min before being treated for 10 min with the SPQ quenching buffer containing KSCN and valinomycin. SPQ fluorescence images were acquired, in each experiment, before preconditioning-simulated ischaemia or prior to pharmacological preconditioning with APNEA, after following 10 min re-oxygenation or washout, and after 10 min incubation in the SPQ quenching solution. To demonstrate that the efflux of Cl 2 induced by preconditioning was indeed the result of volume-regulated Cl 2 channel activity, we also treated a separate group of cardiomyocytes with APNEA in the presence of the Cl 2 channel blocker IAA-94 (50 mM), a drug that does not autofluoresce. We have demonstrated that IAA-94 abolishes IPC cardioprotection in rabbit hearts and isolated cardiomyocytes, and blocks IPC-induced protection against ischaemic cell swelling in cardiomyocytes via inhibition of regulatory volume decrease. 7, 17 To confirm that the intended effect of APNEA on adenosine receptors was indeed specific, we also treated separated groups of cardiomyocytes with either 1 mM APNEA in the presence of the non-specific adenosine receptor blocker 8-p-sulfophenyl theophylline (SPT, 100 mM) or SPT alone. SPT was administered 5 min prior and during APNEA treatment.
In these experiments, the washout period was extended to 60 min. In separate cardiomyocytes, we also monitored the changes in SPQ fluorescence for 4 h during and after exposure to APNEA. Further details of these experiments and additional SPQ fluorescence methodological considerations are presented in the Supplementary material online.
Statistical analysis
All cardiomyocyte fluorescence data were first analysed for normal distribution and equality of variance. ANOVA analysis followed by Scheffe's post hoc test was performed to determine significant differences (P , 0.05) among groups and between two groups, respectively. Where the criteria for parametric analysis were not met, we performed a nonparametric analysis (Kruskal -Wallis followed by Mann-Whitney U) to determine whether a significant difference (P , 0.05) existed between two groups. Data are expressed as mean + SEM.
Results

SPQ loading and leakage
In 24 h cultured cardiomyocytes, 5 mM SPQ loading over a period of 4 h produced a bright fluorescence when exposed to 0 mM Cl 2 solution (using the NO 3 2 substitution as described above in Section 2).
Measurement of the changes in SPQ fluorescence intensity resulting from variations in intracellular Cl
to be subject to errors accruing from photo-bleaching and dye loss.
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This is because the approach, which is based on collision quenching of SPQ fluorescence by halides, is not ratiometric. For this reason, it was important to determine the magnitude of SPQ loss in our cell model. SPQ diffusion to the extracellular medium (SPQ leakage) has been reported in cells to account for a range of SPQ fluorescence between 8 and 10%. 11 In our cultured cardiomyocytes, SPQ fluorescence loss was ,5% after 60 min ( Figure 2 ; see Supplementary material online).
Effect of preconditioning on transsarcolemmal Cl 2 movement
The intracellular concentration of Cl Figure 5) . Also, to confirm that the effect on SPQ fluorescence was indeed the result of activation of adenosine receptors by APNEA, we also treated separate groups of cardiomyocytes either with APNEA in the presence of 100 mM SPT or with SPT alone. Blockade of adenosine receptors, as expected, completely prevented the efflux of Cl 2 induced by APNEA, whereas SPT alone had no effect on SPQ fluorescence ( Figure 5) . In these studies, APNEA induced a significant (P , 0.0001) increase in SPQ fluorescence after 10 min treatment. This level of SPQ fluorescence was subsequently reduced by 30% after the first 10 min of washout but no significant further reduction was observed after 40 min post-treatment ( Figure 5 ). This effect was also blocked by either inhibition of Cl 2 channels with 50 mM IAA-94 or blockade of adenosine receptors with 100 mM SPT ( Figure 5 ). SPT given alone had no effect on SPQ fluorescence ( Figure 5 ). The fast recovery from the initial efflux of Cl , as determined by the rapid partial loss of SPQ fluorescence after APNEA treatment, cannot be explained by the SPQ leakage since the rate of SPQ fluorescence decline was much faster in APNEA-treated cells during the initial 10 min washout period ( 30%, Figure 5 ), when compared with SPQ leakage (,5% after 60 min, Figure 2 ). Complete reversal of the initial increase in SPQ fluorescence caused by APNEA treatment was achieved after nearly 4 h (see Supplementary material online).
Discussion
In this study, we demonstrated for the first time that SPQ-based monitoring of changes in intracellular Cl 2 activity can be used to Measurement of Cl 2 efflux in cardiomyocytes specific treatments such as IPC or APNEA can be measured in cardiomyocytes. In these studies, we have shown that both IPC and APNEA, both known to trigger a Cl 2 channel-dependent enhancement in cell volume regulation leading to protection against ischaemia/reperfusion injury, 17 produced a significant increase in SPQ fluorescence, indicating that the intracellular Cl 2 concentration was significantly reduced. This reduction in intracellular Cl 2 concentration was found to be the result of a net efflux of Cl 2 resulting from adenosine receptor-mediated activation of volume-activated Cl 2 channels, since this effect was abolished both by blockade of adenosine receptors with SPT and by inhibition of Cl 2 channel activity with IAA-94. Both SPT and IAA-94 have been established to inhibit cell volume regulation in rabbit cardiomyocytes.
7,17
The present study shows that the chloride-sensitive dye SPQ can be successfully loaded into intact rabbit ventricular cardiomyocytes in 4 h and SPQ fluorescence recording is suitable to examine kinetics of Cl 2 influx and efflux since the response time of SPQ to changes in chloride concentration is ,1 ms. 9 The sensitivity of SPQ to intracellu- 14 In our studies, we used a well-recognized ionophore calibration based on KSCN and valinomycin. 14 -16 Because the changes in F 0 /F ratios in response to incremental changes in extracellular Cl 2 concentration from 0 to 50 mM were well correlated (r ¼ 0.99), and the SPQ fluorescence data were properly fitted to the Stern-Volmer equation, it was possible to determine the SPQ sensitivity constant for Cl 2 (K sv ) and to estimate the changes in [Cl 2 ] i in response to preconditioning (IPC and APNEA). The fact that the calculated K sv in our studies in cardiomyocytes is consistent with previous K sv measurements performed in other cell types 9, 11, 14 further validates this method. This quantitative halide fluorescence method has limitations. Because SPQ fluorescence is based on collision quenching of the fluorescence by halides, an approach that is not ratiometric, it is therefore prone to errors accruing from photo-bleaching and dye loss. 18, 20 For these reasons, we minimized photo-bleaching in cardiomyocytes by reducing the number and duration of exposure to UV light. Experimentally, it is not possible to separate the combined effect of photobleaching and dye loss due to leakage. In our experiments, the loss of SPQ fluorescence due to this combined effect had a negligible impact on the quantitative assessment of Cl 2 efflux (see Supplementary material online for detail). We emphasize that, as shown in Figure 1 , cations (mostly K + ), across the sarcolemma to the extent of producing a substantial reduction in intracellular osmolarity. These findings are supportive of our hypothesis that IPC enhances cell volume regulation in cardiomyocytes. 17 Therefore, if a given duration of myocardial ischaemia involves the intracellular accumulation of osmotically active osmolytes that result in substantial cell swelling during reperfusion, then an efflux across the cell membranes of cardiomyocytes of an osmotically equivalent quantity of Cl 2 and K + may largely counterbalance the osmotic effect of the intracellular build up of metabolic by-products during myocardial ischaemia, resulting in reduction or prevention of the massive cell swelling and cell death that otherwise occur upon reperfusion following a long period of myocardial ischaemia. The calculated osmotic equivalent of IPC cardioprotection we previously reported in freshly isolated cardiomyocytes roughly approximated 50 mOsm, 17 with 60 mOsm the increase in osmotic strength reached in heart tissue slices during lengthy ischaemia measured by Jennings et al.
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Accumulating evidence points to a pivotal role for the MPTP in cardioprotection induced by preconditioning and, more generally, in the response of the cardiomyocyte to the stress of ischaemia and reperfusion. 24 On MPTP opening, the mitochondrion swells due to osmotic loading, ruptures, and consumes rather than produces ATP. If enough mitochondria are so affected, the cell will die, but the precise details of how these mechanisms produce cell death have not been established. Since it is recognized that mitochondrial volume and cell volume are interdependent, 25 it is plausible that an enhancement of cell volume regulation by IPC may have an impact on mitochondrial swelling and, therefore, on the open/closed state of the MPTP. Determining the role of chloride efflux on inhibition of MPTP opening by IPC remains to be investigated. In summary, the present study demonstrates for the first time that SPQ dye can be used as a Cl 2 indicator in cultured cardiomyocytes, and that a net efflux of Cl 2 is induced by preconditioning either with ischaemia (IPC) or by administration of an adenosine A 1 /A 3 receptor agonist (APNEA) through activation of Cl 2 channels. The identification of the specific Cl 2 channel(s) involved in preconditioning-induced Cl 2 efflux will be the subject of future investigation.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
